---
title: "Apollomics regains Nasdaq compliance on $35 million market value rule"
url: "https://aibio.space/news/apollomics-regains-nasdaq-compliance-35-million-market-value-rule/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-07-14"
section: "Listings"
tickers: "NASDAQ:APLM"
source: "https://www.sec.gov/Archives/edgar/data/1944885/000119312526302494/d31896dex991.htm"
summary: "Nasdaq said on July 8, 2026 that the matter is closed. The company had been notified of the shortfall on June 18, 2026."
---

By the aibio.space news desk.

Sources

- [Apollomics, Inc. 6-K (2026-07-14)](https://www.sec.gov/Archives/edgar/data/1944885/000119312526302494/d31896dex991.htm)

[APLM](https://aibio.space/companies/apollomics/)

2026-07-14

# Apollomics regains Nasdaq compliance on $35 million market value rule

Tickers [APLM](https://aibio.space/companies/apollomics/)

Nasdaq said on July 8, 2026 that the matter is closed. The company had been notified of the shortfall on June 18, 2026.

## Key facts

- **Company**: Apollomics, Inc. (NASDAQ: APLM)

- **News type**: Listings

- **Primary source**: [Apollomics, Inc. 6-K (2026-07-14)](https://www.sec.gov/Archives/edgar/data/1944885/000119312526302494/d31896dex991.htm)

*The Capitol dome seen from below. Photo: U.S. Department of Homeland Security (Source), CC0, via rawpixel. The picture shows the field, not the companies named.*

Apollomics Inc. said on July 13, 2026 that it has regained compliance with Nasdaq's Market Value of Listed Securities (MVLS) requirement. The company received written notice from Nasdaq Listing Qualifications Staff on July 8, 2026, and the matter is now closed.

The rule is Nasdaq Listing Rule 5550(b)(2), which sets a minimum MVLS for continued listing on the Nasdaq Capital Market. Nasdaq notified the company on June 18, 2026 that it was not in compliance because it failed to maintain a minimum MVLS of $35 million over the previous 30 consecutive business days.

Staff has since determined that the company's market value of listed securities was $35 million or greater for the last 10 consecutive business days, from June 23, 2026 to July 7, 2026. On that basis, Apollomics has regained compliance.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

APLM

Apollomics, Inc.

NASDAQ · United States

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/apollomics-regains-nasdaq-compliance-35-million-market-value-rule/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Apollomics regains Nasdaq compliance on $35 million market value rule", 2026-07-14, https://aibio.space/news/apollomics-regains-nasdaq-compliance-35-million-market-value-rule/